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Our studies show that HIV-1 infection provokes a progres-
sive defect in surface TCR/CD3 receptors due to the spe-
cific and escalating loss of CD3 g mRNA. The human CD3
g gene is transcribed from a weak, lymphoid-specific pro-
moter with significant transcription initiation site hetero-
geneity in normal T cells. However, early after HIV-1
infection CD3 g transcripts preferentially initiate at the +1
and +13 with further focusing over time as +1 transcripts
are lost first. Mutant and deletion analysis delimited a 43
bp sequence from the +1 as critical for positive gene
expression. DNA probes covering this sequence do not
bind nuclear proteins. RNA probes from the +1 or +13
specifically bind the cellular proteins Cyclin T1 and cdk9
(P-TEFb) as well as HIV-1 Tat. The +1 to +43 sequence,
defined as the CD3 g RCE (RNA control element), forms
a secondary structure containing a uridine bulge, a side
loop and a double apical loop with sequence similarity to
HIV-1 TAR. Five GGCU repeats present from +18 to +37
form a similar double apical loop structure for +13 tran-
scripts that lack the bulge and side loop. Deletion or
mutation in the CD3 g RCE dramatically affects function
with a 4 nt apical loop mutation abrogating both pro-
moter activity and nuclear protein binding. Co-transfec-
tion of Tat with CD3 g promoter constructs suppresses
promoter activity. In infected cells, knocking down tat
gene expression restores surface TCR/CD3 whereas treat-
ment with Tat protein accelerates TCR/CD3 downmodu-
lation. Thus, P-TEFb binding to the CD3 g RCE in the
presence of Tat is associated with negative transcriptional
regulation.
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